02.25.25 -- Fill/Finish Services, Technologies, And Innovations

Join Darren Hieber as he presents an overview of Lifecore Biomedical’s newly expanded capabilities, designed to meet the growing demands of innovative therapeutics.

From early development through small-scale production to full-scale global commercialization, our proven track record with international regulatory agencies underscores our ability to navigate complex requirements with precision.

Our globally integrated drug product and finished goods services offer agile and flexible solutions for clinical to commercial products. Our services are designed to deliver patient safety and convenience, while offering cost efficiencies and time savings.

Learn about our new facility expansions, enhanced filling capacity, and advanced packaging capabilities that are designed to support and elevate your drug development projects.

Mabion, a biologics CDMO with end-to-end services focusing on recombinant proteins development and production, showcases new depyrogenation, fill finish vial capabilities, and CMC analytical proficiencies.

Kymanox provides turnkey services to bring your product from concept to commercialization — and helps keep your product on the market. Kymanox has expertise in injectables, respiratory combination products, and in ocular products.

Examine how a new high-speed aseptic filling line can help bring your product to market with speed and efficiency while ensuring safety and high product quality.

Discover how Lonza Biologics’ end-to-end Drug Product capabilities support the full lifecycle of biologics, seamlessly integrated with their extensive drug substance network across diverse modalities.

Our capabilities include filling vials (liquid or lyophilized), pre-filled syringes (PFS), and cartridge product types, supporting batch sizes of 1,000 to 100,000 vials and up to 120 batches annually.